已收盘 09-18 16:00:00 美东时间
+0.130
+5.56%
Moleculin Biotech ( ($MBRX) ) has provided an update. Moleculin Biotech, Inc. h...
09-16 20:52
Wally Klemp, CEO of Moleculin, discusses the Company's recent update on the Phase 2 clinical trial of STAT3 inhibitor in combination with radiation for the treatment of glioblastoma Watch th...
09-16 20:30
The latest update is out from Moleculin Biotech (MBRX). Moleculin Biotech, Inc....
08-20 04:29
The latest announcement is out from Moleculin Biotech (MBRX). Moleculin Biotech...
08-17 05:17
Moleculin Biotech (NASDAQ:MBRX) announced the pricing of a public offering of about 2.5M shares of its common stock, Series A warrants to purchase up to 2.5M shares of common stock and Series B warran...
08-16 20:44
Moleculin Biotech - Series a Warrants Exercise Price $2.23
08-16 20:04
Moleculin Biotech- Believes Existing Cash and Cash Equivalents as of June 30 to...
08-14 20:07
Moleculin Biotech (MBRX) just unveiled an announcement. Moleculin Biotech, Inc....
07-10 20:59
Moleculin Biotech Inc: 89% Of Crc's Were Subjects With "Poor Prognosis" Cytogen...
06-14 20:00
Moleculin Biotech Inc: Current Median Durability of Response (Mdor) of Crc's = ...
06-14 20:00